These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38023160)

  • 1. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas.
    Tomacinschii V; Mosquera Orgueira A; Santos CA; Robu M; Buruiana S; Fraga Rodriguez MF
    Front Oncol; 2023; 13():1275327. PubMed ID: 38023160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
    Heimann P; Dewispelaere L
    Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopathology of childhood, adolescent and young adult non-Hodgkin lymphoma.
    Lim MS; Foley M; Mussolin L; Siebert R; Turner S
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101447. PubMed ID: 36907637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.
    Bohers E; Mareschal S; Bertrand P; Viailly PJ; Dubois S; Maingonnat C; Ruminy P; Tilly H; Jardin F
    Leuk Lymphoma; 2015 May; 56(5):1213-22. PubMed ID: 25130477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma.
    Fontanilles M; Marguet F; Bohers É; Viailly PJ; Dubois S; Bertrand P; Camus V; Mareschal S; Ruminy P; Maingonnat C; Lepretre S; Veresezan EL; Derrey S; Tilly H; Picquenot JM; Laquerrière A; Jardin F
    Oncotarget; 2017 Jul; 8(29):48157-48168. PubMed ID: 28636991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic dissection of the molecular mechanism of malignant lymphoma using advanced genomic technology].
    Shingaki S; Kataoka K
    Rinsho Ketsueki; 2022; 63(9):1058-1066. PubMed ID: 36198530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing in routine diagnostics of mature non-Hodgkin's B-cell lymphomas.
    Breinholt MF; Schejbel L; Gang AO; Nielsen TH; Pedersen LM; Høgdall E; Nørgaard P
    Eur J Haematol; 2023 Oct; 111(4):583-591. PubMed ID: 37452559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomics of diffuse large B cell lymphoma.
    Koh Y
    Blood Res; 2021 Apr; 56(S1):S75-S79. PubMed ID: 33935039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.
    Esmeray E; Küçük C
    Turk J Biol; 2020; 44(1):1-14. PubMed ID: 32123491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Genetics on Mature Lymphoid Leukemias and Lymphomas.
    Bailey NG; Elenitoba-Johnson KSJ
    Cold Spring Harb Perspect Med; 2020 Nov; 10(11):. PubMed ID: 31932467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of transcription factors PAX5, OCT2, BCL6 and transcription regulator P53 in Non-Hodgkin lymphomas: A diagnostic cross-sectional study.
    Ismail S; Elshimali Y; Daoud A; Alshehabi Z
    Ann Med Surg (Lond); 2022 Jun; 78():103786. PubMed ID: 35600178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Next-Generation Sequencing Highlights of Diffuse Large B-cell Lymphoma in a Tertiary Care Hospital in North India.
    Mamgain G; Naithani M; Patra P; Mamgain M; Morang S; Nayak J; Kumar K; Singh S; Bakliwal A; Rajoreya A; Vaniyath S; Chattopadhyay D; Chetia R; Gupta A; Dhingra G; Sundriyal D; Nath UK
    Cureus; 2022 Aug; 14(8):e28241. PubMed ID: 36158348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed cell death ligand 1 expression in aggressive pediatric non-Hodgkin lymphomas: frequency, genetic mechanisms, and clinical significance.
    Fisher KE; Ferguson LS; Coffey AM; Merritt BY; Curry JL; Marcogliese AN; Major AM; Kamdar KY; Lopez-Terrada DH; Curry CV
    Haematologica; 2022 Aug; 107(8):1880-1890. PubMed ID: 35081690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.
    Jardin F
    Discov Med; 2014; 18(97):51-65. PubMed ID: 25091488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newly identified mechanisms in B-cell non-Hodgkin lymphomas uncovered by next-generation sequencing.
    Morin RD; Gascoyne RD
    Semin Hematol; 2013 Oct; 50(4):303-13. PubMed ID: 24246698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T-cell lymphomas with pathogenic somatic mutations and absence of detectable clonal T-cell receptor gene rearrangement: two case reports.
    Rojansky R; Fernandez-Pol S; Wang E; Rieger KE; Novoa RA; Zehnder JL; Kunder CA; Kim YH; Khodadoust MS; Brown RA
    Diagn Pathol; 2020 Sep; 15(1):122. PubMed ID: 32988392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation sequencing discoveries in lymphoma.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2013 Mar; 20(2):110-6. PubMed ID: 23399796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.